Your browser doesn't support javascript.
loading
Global hypo-methylation in a proportion of glioblastoma enriched for an astrocytic signature is associated with increased invasion and altered immune landscape.
Boot, James; Rosser, Gabriel; Kancheva, Dailya; Vinel, Claire; Lim, Yau Mun; Pomella, Nicola; Zhang, Xinyu; Guglielmi, Loredana; Sheer, Denise; Barnes, Michael; Brandner, Sebastian; Nelander, Sven; Movahedi, Kiavash; Marino, Silvia.
Affiliation
  • Boot J; Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University, London, United Kingdom.
  • Rosser G; Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University, London, United Kingdom.
  • Kancheva D; Laboratory for Molecular and Cellular Therapy, Vrije Universiteit Brussel, Brussels, Belgium.
  • Vinel C; Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University, London, United Kingdom.
  • Lim YM; Division of Neuropathology, The National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, and Department of Neurodegenerative Disease, Queen Square, Institute of Neurology, University College London, London, United Kingdom.
  • Pomella N; Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University, London, United Kingdom.
  • Zhang X; Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University, London, United Kingdom.
  • Guglielmi L; Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University, London, United Kingdom.
  • Sheer D; Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University, London, United Kingdom.
  • Barnes M; Centre for Translational Bioinformatics, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
  • Brandner S; Division of Neuropathology, The National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, and Department of Neurodegenerative Disease, Queen Square, Institute of Neurology, University College London, London, United Kingdom.
  • Nelander S; Department of Immunology Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • Movahedi K; Laboratory for Molecular and Cellular Therapy, Vrije Universiteit Brussel, Brussels, Belgium.
  • Marino S; Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University, London, United Kingdom.
Elife ; 112022 11 22.
Article in En | MEDLINE | ID: mdl-36412091
ABSTRACT
We describe a subset of glioblastoma, the most prevalent malignant adult brain tumour, harbouring a bias towards hypomethylation at defined differentially methylated regions. This epigenetic signature correlates with an enrichment for an astrocytic gene signature, which together with the identification of enriched predicted binding sites of transcription factors known to cause demethylation and to be involved in astrocytic/glial lineage specification, point to a shared ontogeny between these glioblastomas and astroglial progenitors. At functional level, increased invasiveness, at least in part mediated by SRPX2, and macrophage infiltration characterise this subset of glioblastoma.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Glioblastoma Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Humans Language: En Journal: Elife Year: 2022 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Glioblastoma Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Humans Language: En Journal: Elife Year: 2022 Document type: Article Affiliation country:
...